Understanding the Effects of Long Covid on Lungs
Like other respiratory conditions, COVID-19 can harm the lungs permanently. Based on a person’s immune system, age, and comorbidities, COVID-19 can have multiple effects on the respiratory system and cause different degrees of severity. Symptoms include coughing, shortness of breath, and fever, serious such as respiratory failure, shock, and multiple organ failure.
It is crucial to remember that patients with underlying lung diseases might face elevated issues in addition to their illness as a result of contracting or being exposed to COVID-19. This means that illnesses like asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease could become more severe overall as a result of COVID-19.
What are the short-term repercussions of COVID-19 on the lungs for those who are diagnosed with it and later recover?
According to the World Health Organisation, a moderate infection may take two weeks to recover from, while a serious illness may take three to six weeks. But in addition to the severity of the sickness, this varies and is based on a patient’s pre-existing comorbidities.
Patients typically report dyspnea (43%), weariness (53%), joint discomfort, and chest pain as their main complaints. However, cases of serious illnesses that persist for weeks at a time, include pneumonia in immuno suppressed individuals.
Patients may experience persistent symptoms even with less severe infections. Only 65% of respondents in a recent poll indicated that their health had returned to normal in 14 to 21 days after diagnosis. Those who did regain their pre-diagnosis levels of health did so on average, seven days later.
Can COVID-19 damage lungs permanently?
The risk of long-term consequences is indeed higher for those with chronic lung injury. Data from severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS) suggests that up to 50% of COVID-19 patients may have some lung damage, although this is unknown.
Can lung damage caused by Conoravirus be repaired in any way? How likely is it that someone who has been infected will recover full lung function?
The risk of long-term consequences is indeed higher for those with chronic lung injury. Data from severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS) suggests that up to 50% of COVID-19 patients may have some lung damage, although this is unknown.
Similar to recovering from pneumonia, individuals’ lung function can improve with time. Studies that followed patients after they developed pulmonary fibrosis revealed that pulmonary lesions decreased predominantly in the first year after recovery, in line with earlier findings with SARS and MERS coronaviruses. The difficulty arises when lung fibrosis develops in cases of severe inflammation. Epithelial damage and fibroblast activation are possible consequences of chronic inflammation, which have been theorised to be the primary cause of pulmonary fibrosis.
Giloy (Guduchi) Herb, an Ayurvedic Treatment for Lung Damage
Guduchi (Giloy) is regarded as one of the three Amrit plants in Ayurvedic treatment. Because of the properties of this climber plant, it is called “Amritavalli” in Sanskrit ( Amrit means immortality in Sanskrit).
In Ayurvedic literature, Guduchi is well-documented. The ayurvedic view of Guduchi as a Rasayana (rejuvenator) and an immunity booster is confirmed by scientific studies. Other beneficial properties of this medicinal herb include Immunomodulatory, hepatoprotective, cardioprotective, antiinflammatory, antioxidant and Analgesic effect.
A natural remedy called CelWel helps the immune system redevelop and combats the signs and symptoms of Long Covid and other disorders. It utilises the power of Molecular Signalling and healing effects of Guduchi for a quicker recovery from chronic fatigue, exhaustion, breathing difficulties, fever, and many other associated ailments.
Give your immune system the assistance it needs right now through CelWel Ayurvedic Immunity Booster and help relieve the after effects of Covid.
